|
1
|
Kömür M, Erbey F, Bayram I and Tanyeli A:
Incidence and prognostic importance of molecular genetic defects in
children with acute myeloblastic leukemia. Asian Pac J Cancer Prev.
11:1393–1395. 2010.PubMed/NCBI
|
|
2
|
Gilliland DG: Molecular genetics of human
leukemia. Leukemia. 12(Suppl 1): S7–S12. 1998.PubMed/NCBI
|
|
3
|
Rowley JD, Golomb HM and Dougherty C:
15–17 translocation, a consistent chromosome change in acute
promyelocytic leukemia. Lancet. 1:549–50. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Melnick A and Licht JD: Deconstructing a
disease: RARalpha, its fusion partners and their roles in the
pathogenesis of acute promyelocytic leukemia. Blood. 93:3167–3215.
1999.PubMed/NCBI
|
|
5
|
Burnett AK, Grimwade D, Solomon E,
Wheatley K and Goldstone AH: Presenting white blood cell count and
kinetics of molecular remission predict prognosis in acute
promyelocytic leukemia treated with all-trans retinoic acid: Result
of the Randomized MRC Trial. Blood. 93:4131–4143. 1999.PubMed/NCBI
|
|
6
|
Fenaux P, Chastang C, Chevret S, Sanz M,
Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, et al:
A randomized comparison of all transretinoic acid (ATRA) followed
by chemotherapy and ATRA plus chemotherapy and the role of
maintenance therapy in newly diagnosed acute promyelocytic
leukemia. The European APL Group. Blood. 94:1192–1200.
1999.PubMed/NCBI
|
|
7
|
Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ,
Si GY, Jin XL, Tang W, Li XS, Xong SM, et al: In vitro studies on
cellular and molecular mechanisms of arsenic trioxide
(As2O3) in the treatment of acute
promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with
downregulation of Bcl-2 expression and modulation of PML-RAR
alpha/PML proteins. Blood. 88:1052–1061. 1996.PubMed/NCBI
|
|
8
|
Lam MS and Ignoffo RJ: Arsenic trioxide
for the treatment of acute promyelocytic leukemia. Cancer Pract.
9:155–157. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bawa-Khalfe T and Yeh ET: SUMO losing
balance: SUMO proteases disrupt SUMO homeostasis to facilitate
cancer development and progression. Genes Cancer. 1:748–752. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng J, Kang X, Zhang S and Yeh ET:
SUMO-specific protease 1 is essential for stabilization of
HIF1alpha during hypoxia. Cell. 131:584–595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu L, Ji W, Zhang H, Renda MJ, He Y, Lin
S, Cheng EC, Chen H, Krause DS and Min W: SENP1-mediated GATA1
deSUMOylation is critical for definitive erythropoiesis. J Exp Med.
207:1183–1195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu B, Wang T, Mei W, Li D, Cai R, Zuo Y
and Cheng JK: Small ubiquitin-like modifier (SUMO) protein-specific
protease 1 de-SUMOylates Sharp-1 protein and controls adipocyte
differentiation. J Biol Chem. 289:22358–22364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu J, Fan Y, Liu X, Zhou L, Cheng J, Cai R
and Xue S: SENP1 protects against myocardial ischaemia/reperfusion
injury via a HIF1α-dependent pathway. Cardiovasc Res. 104:83–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bawa-Khalfe T, Cheng J, Lin SH, Ittmann MM
and Yeh ET: SENP1 induces prostatic intraepithelial neoplasia
through multiple mechanisms. J Biol Chem. 285:25859–25866. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Y, Li J, Zuo Y, Deng J, Wang LS and
Cheng GQ: SUMO-specific protease 1 regulates the in vitro and in
vivo growth of colon cancer cells with the upregulated expression
of CDK inhibitors. Cancer Lett. 309:78–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma C, Wu B, Huang X, Yuan Z, Nong K, Dong
B, Bai Y, Zhu H, Wang W and Ai K: SUMO-specific protease 1
regulates pancreatic cancer cell proliferation and invasion by
targeting MMP-9. Tumour Biol. 35:12729–12735. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang RT, Zhi XY, Zhang Y and Zhang J:
Inhibition of SENP1 induces radiosensitization in lung cancer
cells. Exp Ther Med. 6:1054–1058. 2013.PubMed/NCBI
|
|
18
|
Jiang Z, Fan Q, Zhang Z, Zou Y, Cai R,
Wang Q, Zuo Y and Cheng J: SENP1 deficiency promotes ER
stress-induced apoptosis by increasing XBP1 SUMOylation. Cell
Cycle. 11:1118–1122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang BB, Gao QM, Liang W, Xiu B, Zhang WJ
and Liang AB: Downregulation of SENP1 expression increases
apoptosis of Burkitt lymphoma cells. Asian Pac J Cancer Prev.
13:2045–2049. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sharma P, Murillas R, Zhang H and Kuehn
MR: N4BP1 is a newly identified nucleolar protein that undergoes
SUMO-regulated polyubiquitylation and proteasomal turnover at
promyelocytic leukemia nuclear bodies. J Cell Sci. 123:1227–1234.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohbayashi N, Kawakami S, Muromoto R, Togi
S, Ikeda O, Kamitani S, Sekine Y, Honjoh T and Matsuda T: The IL-6
family of cytokines modulates STAT3 activation by desumoylation of
PML through SENP1 induction. Biochem Biophys Res Commun.
371:823–828. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kastner P, Perez A, Lutz Y, Rochette-Egly
C, Gaub MP, Durand B, Lanotte M, Berger R and Chambon P: Structure,
localization and transcriptional properties of two classes of
retinoic acid receptor alpha fusion proteins in acute promyelocytic
leukemia (APL): Structural similarities with a new family of
oncoproteins. EMBO J. 11:629–642. 1992.PubMed/NCBI
|
|
23
|
Mollereau B, Manié S and Napoletano F:
Getting the better of ER stress. J Cell Commun Signal. 8:311–321.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gorman AM, Healy SJ, Jäger R and Samali A:
Stress management at the ER: Regulators of ER stress-induced
apoptosis. Pharmacol Ther. 134:306–316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mathur A, Abd Elmageed ZY, Liu X,
Kostochka ML, Zhang H, Abdel-Mageed AB and Mondal D: Subverting
ER-stress towards apoptosis by nelfinavir and curcumin coexposure
augments docetaxel efficacy in castration resistant prostate cancer
cells. PLoS One. 9:e1031092014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kondo S, Hino SI, Saito A, Kanemoto S,
Kawasaki N, Asada R, Izumi S, Iwamoto H, Oki M, Miyagi H, et al:
Activation of OASIS family, ER stress transducers, is dependent on
its stabilization. Cell Death Differ. 19:1939–1949. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin L, Wang Z, Tao L and Wang Y: ER stress
negatively regulates AKT/TSC/mTOR pathway to enhance autophagy.
Autophagy. 6:239–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chiu HW, Tseng YC, Hsu YH, Lin YF, Foo NP,
Guo HR and Wang YJ: Arsenic trioxide induces programmed cell death
through stimulation of ER stress and inhibition of the
ubiquitin-proteasome system in human sarcoma cells. Cancer Lett.
356:762–772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li K, Zhang L, Xiang X, Gong S, Ma L, Xu
L, Wang G, Liu Y, Ji X, Liu S, et al: Arsenic trioxide alleviates
airway hyperresponsiveness and promotes apoptosis of
CD4+ T lymphocytes: Evidence for involvement of the ER
stress-CHOP pathway. Ir J Med Sci. 182:573–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doudican NA, Wen SY, Mazumder A and Orlow
SJ: Sulforaphane synergistically enhances the cytotoxicity of
arsenic trioxide in multiple myeloma cells via stress-mediated
pathways. Oncol Rep. 28:1851–1858. 2012.PubMed/NCBI
|
|
31
|
Zhang H, Duncan G, Wang L, Liu P, Cui H,
Reddan JR, Yang BF and Wormstone IM: Arsenic trioxide initiates ER
stress responses, perturbs calcium signalling and promotes
apoptosis in human lens epithelial cells. Exp Eye Res. 85:825–835.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan YH, Chen M, Meng J, Yu L, Tu Y, Wan L,
Fang K and Zhu W: Arsenic trioxide and resveratrol show synergistic
anti-leukemia activity and neutralized cardiotoxicity. PLoS One.
9:e1058902014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu M, Yang Y, Wang C, Sun L, Mei C, Yao
W, Liu Y, Shi Y, Qiu S, Fan J, et al: The effect of epidermal
growth factor receptor variant III on glioma cell migration by
stimulating ERK phosphorylation through the focal adhesion kinase
signaling pathway. Arch Biochem Biophys. 502:89–95. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang C, Yang Y, Yang Z, Liu M, Li Z, Sun
L, Mei C, Chen H, Chen L, Wang L and Zha X: EGF-mediated migration
signaling activated by N-acetylglucosaminyltransferase-V via
receptor protein tyrosine phosphatase kappa. Arch Biochem Biophys.
486:64–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghaffari SH, Bashash D, Dizaji MZ,
Ghavamzadeh A and Alimoghaddam K: Alteration in miRNA gene
expression pattern in acute promyelocytic leukemia cell induced by
arsenic trioxide: A possible mechanism to explain arsenic
multi-target action. Tumour Biol. 33:157–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ghaffari SH, Momeny M, Bashash D, Mirzaei
R, Ghavamzadeh A and Alimoghaddam K: Cytotoxic effect of arsenic
trioxide on acute promyelocytic leukemia cells through suppression
of NFkβ-dependent induction of hTERT due to downregulation of Pin1
transcription. Hematology. 17:198–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao XY, Yang S, Chen YR, Li PC, Dou MM
and Zhang J: Resveratrol and arsenic trioxide act synergistically
to kill tumor cells in vitro and in vivo. PLoS One. 9:e989252014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
So AY, de la Fuente E, Walter P, Shuman M
and Bernales S: The unfolded protein response during prostate
cancer development. Cancer Metastasis Rev. 28:219–223. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamamoto K, Tashiro E and Imoto M:
Quinotrierixin inhibited ER stress-induced XBP1 mRNA splicing
through inhibition of protein synthesis. Biosci Biotechnol Biochem.
75:284–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nasr R, Lallemand-Breitenbach V, Zhu J,
Guillemin MC and de Thé H: Therapy-induced PML/RARA proteolysis and
acute promyelocytic leukemia cure. Clin Cancer Res. 15:6321–6326.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Geoffroy MC, Jaffray EG, Walker KJ and Hay
RT: Arsenic-induced SUMO-dependent recruitment of RNF4 into PML
nuclear bodies. Mol Biol Cell. 21:4227–4239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J,
Cai X, Han ZG, Ni JH, Shi GY, Jia PM, et al: Use of arsenic
trioxide (As2O3) in the treatment of acute promyelocytic leukemia
(APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
Blood. 89:3345–3353. 1997.PubMed/NCBI
|
|
43
|
Khaleghian A, Ghaffari SH, Ahmadian S,
Alimoghaddam K and Ghavamzadeh A: Metabolism of arsenic trioxide in
acute promyelocytic leukemia cells. J Cell Biochem. 115:1729–1739.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sumi D, Shinkai Y and Kumagai Y: Signal
transduction pathways and transcription factors triggered by
arsenic trioxide in leukemia cells. Toxicol Appl Pharmacol.
244:385–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang J, Li L, Cang H, Shi G and Yi J:
NADPH oxidase-derived reactive oxygen species are responsible for
the high susceptibility to arsenic cytotoxicity in acute
promyelocytic leukemia cells. Leuk Res. 32:429–436. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tabellini G, Cappellini A, Tazzari PL,
Falà F, Billi AM, Manzoli L, Cocco L and Martelli AM:
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide
resistance of human leukemia cells. J Cell Physiol. 202:623–634.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tabellini G, Tazzari PL, Bortul R,
Evangelisti C, Billi AM, Grafone T, Martinelli G, Baccarani M and
Martelli AM: Phosphoinositide 3-kinase/Akt inhibition increases
arsenic trioxide-induced apoptosis of acute promyelocytic and
T-cell leukaemias. Br J Haematol. 130:716–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Binet F, Chiasson S and Girard D: Evidence
that endoplasmic reticulum (ER) stress and caspase-4 activation
occur in human neutrophils. Biochem Biophys Res Commun. 391:18–23.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Y and Dasso M: SUMOylation and
deSUMOylation at a glance. J Cell Sci. 122:4249–4252. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Verger A, Perdomo J and Crossley M:
Modification with SUMO. A role in transcriptional regulation. EMBO
Rep. 4:137–142. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Quentin T, Steinmetz M, Poppe A and Thoms
S: Metformin differentially activates ER stress signaling pathways
without inducing apoptosis. Dis Model Mech. 5:259–269. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ibuki T, Yamasaki Y, Mizuguchi H and
Sokabe M: Protective effects of XBP1 against oxygen and glucose
deprivation/reoxygenation injury in rat primary hippocampal
neurons. Neurosci Lett. 518:45–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
